We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Approach to the Treatment of a Patient with an Aggressive Pituitary Tumor.
- Authors
Lin, Andrew L.; Donoghue, Mark T. A.; Wardlaw, Sharon L.; Jonathan Yang, T.; Bodei, Lisa; Tabar, Viviane; Geer, Eliza B.; Yang, T Jonathan
- Abstract
A small subset of pituitary adenomas grows despite maximal treatment with standard therapies; namely, surgery and radiotherapy. These aggressive tumors demonstrate 2 patterns of growth: they may be locally aggressive or metastasize distantly, either hematogenously or through the spinal fluid. Further surgery and radiotherapy may be helpful for palliation of symptoms, but they are rarely definitive in the management of these malignant tumors. The only chemotherapy with established activity in the treatment of pituitary tumors is the alkylating agent temozolomide. At most, 50% of patients exhibit an objective response to temozolomide and the median time to progression is short; thus, there remains a significant unmet need for effective treatments within this patient population. Several targeted agents have reported activity in this tumor type-including small molecule inhibitors, checkpoint inhibitors, and other biologics-but remain investigational at this time.
- Subjects
PITUITARY tumors; RADIATION tolerance; HEARING disorders; PITUITARY gland; THERAPEUTICS; DRUG side effects; EXOMES
- Publication
Journal of Clinical Endocrinology & Metabolism, 2020, Vol 105, Issue 12, p1
- ISSN
0021-972X
- Publication type
journal article
- DOI
10.1210/clinem/dgaa649